The U.S. FDA’s effort to compile a guidance for prescription, point-of-care (POC) blood glucose meter (BGM) test systems seems to show that guidances can be as iterative as the devices they govern.
Salvatore Viscomi MD, co-founder of Carna Health is an entrepreneur with a passion for digital health and remote patient monitoring. The Covid-19 pandemic taught us that providing care outside of ...
LONDON – After eight years in development, Memed Diagnostics Ltd. has secured CE marking for its point-of-care blood test, which is able to distinguish between bacterial and viral infections in 15 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results